CBT-I vs. MBTI for TBI-Related Insomnia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two therapies to treat insomnia and reduce depressive symptoms in individuals with mild to moderate traumatic brain injury (TBI) and post-traumatic stress symptoms (PTSS). One group will undergo cognitive behavioral therapy for insomnia (CBT-I), which focuses on changing sleep habits and thoughts about sleep. The other group will try mindfulness-based treatment for insomnia (MBTI), combining mindfulness exercises with sleep behavior strategies. The trial aims to determine which therapy more effectively improves sleep. Ideal participants are current or former military members who have experienced TBI and insomnia for over 90 days and have computer access. As an unphased trial, this study provides a unique opportunity to explore innovative therapies for enhancing sleep and mental health.
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications, but if you are using psychotropic medications, you need to be on a stable dosage for at least three weeks before the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both cognitive behavioral therapy for insomnia (CBT-I) and mindfulness-based treatment for insomnia (MBTI) are generally safe. Studies indicate that CBT-I helps 70 to 80% of people with insomnia achieve long-lasting improvements. Often recommended over sleeping pills, CBT-I is well-tolerated with few side effects.
For MBTI, research has found it can improve sleep and reduce the mental stress that worsens insomnia. Although detailed safety data for MBTI is limited, its focus on mindfulness practices, such as meditation and relaxation, is usually considered safe.
Overall, both treatments do not involve medication, reducing the risk of serious side effects. Participants typically find these treatments easy to handle.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for TBI-related insomnia because they offer innovative approaches to managing sleep issues. Unlike traditional treatments that might rely on medication, both Cognitive Behavioral Therapy for Insomnia (CBT-I) and Mindfulness-Based Treatment for Insomnia (MBTI) focus on non-drug strategies. CBT-I uniquely combines cognitive and behavioral techniques, such as cognitive restructuring and sleep restriction, to change sleep habits and thoughts about sleep. MBTI integrates mindfulness with sleep restriction and stimulus control, promoting awareness and reducing hyperarousal. These approaches aim to address insomnia's root causes, offering potentially effective and long-lasting solutions without relying on medications.
What evidence suggests that this trial's treatments could be effective for TBI-related insomnia?
Research has shown that cognitive behavioral therapy for insomnia (CBT-I), one of the treatments in this trial, works well, with 70 to 80% of patients experiencing long-lasting benefits. One study found that CBT-I helped people fall asleep faster and wake up less during the night. Mindfulness-based treatment for insomnia (MBTI), another treatment option in this trial, also appears promising. It improves sleep by increasing awareness of sleep-friendly habits and reducing stress. A study on a similar mindfulness program showed that participants' insomnia symptoms improved. Both treatments have strong evidence supporting their effectiveness in enhancing sleep quality.15678
Who Is on the Research Team?
Luis Buenaver, PhD
Principal Investigator
Johns Hopkins School of Medicine
Are You a Good Fit for This Trial?
This trial is for adults over 18 with mild to moderate traumatic brain injury (TBI) who have insomnia and post-traumatic stress symptoms. They must have had the TBI for at least 3 weeks, show signs of insomnia, be able to give informed consent, and use a computer.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either CBT-I or MBTI treatment over 6 sessions delivered via telemedicine
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 2-, 6-, and 12-weeks post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive behavioral therapy for insomnia (CBT-I)
- Mindfulness-based treatment for insomnia (MBTI)
Cognitive behavioral therapy for insomnia (CBT-I) is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Department of Defense Congressionally Directed Medical Research Program
Collaborator